Global ECMO Machine Market Outlook
Revenue, 2024
$533M
Forecast, 2034
$918M
CAGR, 2025 - 2034
5.6%
The ECMO Machine industry revenue is expected to be around $562.6 million in 2025 and expected to showcase growth with 5.6% CAGR between 2025 and 2034. The growing need for ECMO Machine demonstrates their essential role in contemporary critical care equipment because severe respiratory failure cases and complex cardiac conditions and aging patients with multiple health issues continue to increase.
The ECMO Machine takes blood from the patient adds oxygen to the blood removes carbon dioxide and then sends the blood back into the body. The ECMO Machine gives short term life support when the lungs or heart are badly failing. Key features of the ECMO Machine are pumps, efficient oxygenators, heparin coated circuits, monitoring interfaces and safety alarms that track many parameters. The ECMO Machine uses these parts to help patients in care units and, in cardiac surgery. Major applications span acute respiratory distress syndrome, cardiogenic shock, perioperative cardiopulmonary support, and bridge to transplant therapy, while recent trends such as miniaturized portable ECMO systems, improved biocompatible materials, and standardized protocols in specialized centers are expanding access and consolidating the ECMO Machine position at the core of advanced cardiopulmonary support.
Market Key Insights
The Ecmo Machine market will expand from $532.8 million in 2024 to reach $919 million by 2034. The market will expand at a 5.6% annual rate because of increasing needs for Respiratory Support and Cardiac Support and Emergency ECPR applications.
Getinge AB, Medtronic plc, and Terumo are among the leading players in this market, shaping its competitive landscape.
The Ecmo Machine market leads with the United States and China as its main customer bases which will experience growth at 3.6% to 5.4% CAGR from 2024 to 2030.
The market research predicts India, Brazil and Saudi Arabia will experience the highest growth rate at 6.4% to 7.7% CAGR.
Transition like AI-Enabled ECMO Workflows has greater influence in U.S. and China market's value chain; and is expected to add $19 million of additional value to Ecmo Machine industry revenue by 2030.
.The Ecmo Machine market will experience $386 million growth during 2024-2034 because manufacturers focus on developing Cardiac & ECPR Application solutions which will dominate market expansion.
With
rising burden of severe cardiopulmonary disease and wider icu adoption of ecmo machines for life support, and
Technological Advancements Improving ECMO Machine Safety, Circuit Efficiency, and Integration with Digital Critical Care Platforms, Ecmo Machine market to expand 72% between 2024 and 2034.
Opportunities in the ECMO Machine
The Japanese emergency medical system uses portable ECMO Machine to start extracorporeal cardiopulmonary resuscitation for patients with unresponsive cardiac arrest during ambulance transportation. The combination of an aging population with dense urban areas and advanced critical care facilities makes Japan an ideal location for pre hospital ECMO deployment. The development of miniaturized veno arterial ECMO systems for ambulance use receives support from manufacturer university hospital ambulance service partnerships. The market for portable ECMO Machine for treating cardiac arrest and cardiogenic shock outside hospitals will also experience the fastest growth rate.
Growth Opportunities in North America and Asia-Pacific
The ECMO Machine market in North America depends mainly on cardiac centers that operate at high levels of intensity because they need advanced cardiopulmonary support systems for complex surgical procedures. The market benefits from multiple intensive care units throughout the region and strong payment coverage for ECMO procedures and hospitals quick adoption of data based ECMO systems. The market competition remains high because major worldwide companies and specialized medical device developers fight for dominance through their ability to deliver better clinical results and their expertise in device design and system integration with essential critical care technology platforms. The market demands advanced cardiac focused ECMO Machine which should feature longer lasting oxygenators and portable designs for hospital to hospital transfers and complete training solutions and simulation programs and maintenance services for busy medical facilities.
The ECMO Machine market in Asia Pacific shows Respiratory applications as its leading segment because of the regions severe acute respiratory failure cases and its active effort to enhance intensive care facilities. The region experiences fast growing ECPR adoption rates in its technologically advanced nations while Respiratory applications maintain their leading position in the ECMO Machine market. The market growth stems from three main factors which include healthcare facility development and government funding for advanced medical facilities and enhanced readiness to handle respiratory outbreaks that need expandable ECMO systems. The market competition exists between high end imported ECMO systems and local manufacturers who compete through affordable prices and flexible solutions for different hospital sizes and dedicated clinical assistance. The market requires ECMO Machine configurations that minimize costs and modular platforms which enable hospitals to select between Respiratory and ECPR treatment protocols and sustained partnerships with healthcare facilities for training and maintenance and outcome based clinical programs.
Market Dynamics and Supply Chain
01
Driver: Rising Burden of Severe Cardiopulmonary Disease and Wider ICU Adoption of ECMO Machine for Life Support
The rising number of patients with advanced heart failure and cardiogenic shock and acute respiratory distress syndrome has also created an increased need for extracorporeal membrane oxygenation treatment in tertiary hospitals. Medical staff now use each ECMO Machine at an earlier stage to treat patients with reversible cardiac and respiratory failure especially in neonatal and pediatric intensive care units where survival advantages have also become more evident. The growing number of ICU facilities using ECMO Machine also stems from cardiac surgery and transplant centers uniting into large volume centers which establish standardized extracorporeal life support guidelines. The facilities that specialize in critical care have also purchased expandable critical care equipment and trained dedicated ECMO staff and conducted simulation based training to enhance their results. Hospitals continue to increase their ECMO device installations because they understand the device functions as a temporary solution to support patients until they recover or receive a transplant or ventricular assist device.
The ECMO Machine undergoes transformation from its current complex open system design into an integrated user friendly critical care platform because of fast technological progress. The combination of heparin coated surfaces with low resistance oxygenators and magnetically levitated pumps in next generation circuits works to decrease hemolysis and thrombosis and inflammatory reactions which results in better patient outcomes and consistent treatment results. The new design of ECMO Machine features automatic flow management and pressure and gas exchange control systems which enable their use in busy ICUs and during medical transfers between hospitals. The integration of digital monitoring systems with electronic health records through seamless connectivity allows for real time analytics and alarm systems and protocol based decision support which reduces operational work and speeds up clinical choices for hospitals with different configurations.
02
Restraint: Escalating procedure costs and limited reimbursement significantly constrain widespread adoption of advanced ECMO Machine systems
The high cost of ECMO Machine and their associated extracorporeal membrane oxygenation disposables and staff requirements limit hospital purchases and extend replacement periods which restricts revenue expansion for ECMO device manufacturers. The lack of complete reimbursement for cardiopulmonary support procedures in various areas leads hospitals to select less expensive critical care equipment which decreases demand even though intensive care unit requirements are increasing. The market for ECMO devices faces challenges because large tertiary centers dominate device usage which reduces the potential customer base and creates unpredictable procurement habits that make it difficult to predict market trends and set prices effectively.
03
Opportunity: Rising demand for neonatal ECMO components in specialized pediatric intensive care units across Western Europe and Expanding use of ECMO Machine for severe respiratory failure in rapidly modernizing Tier II Indian hospitals
The number of patients with congenital heart disease and neonatal respiratory failure in Western European pediatric intensive care units continues to rise but the availability of ECMO components designed for newborns remains insufficient. The consolidation of high risk medical cases within hospital networks creates increased requirements for specialized equipment including oxygenators and cannulas and single use circuits that match the needs of infants. The global ECMO component market will expand from 359.11 to 512.29 million during the next ten years at a 6.1% annual growth rate which will create opportunities for neonatal cardiopulmonary support consumables to achieve superior market expansion in this region.
The ECMO Machine market in India focuses on major metropolitan hospitals which serve only a small portion of patients because Tier II hospitals lack access to these machines despite increasing cases of acute respiratory distress and pneumonia. The combination of fast paced ICU development and expanded insurance benefits and rising critical care department understanding of ECMO technology creates rising market potential. The market for veno venous ECMO Machine for respiratory failure will experience the fastest growth because they will lead the projected global ECMO Machine revenue expansion from 173.69 to 226.54 million during 2030.
04
Challenge: Severe shortage of trained ECMO specialists and infrastructure restricts operational capacity across intensive care units
The absence of trained perfusionists and intensivists and ECMO nurses at hospitals prevents them from using their installed ECMO Machine capacity which restricts procedure numbers and reduces consumable revenue potential. The absence of dedicated ECMO programs and proper monitoring systems at facilities prevents them from performing complex cases like acute respiratory distress syndrome which reduces their potential to increase procedure numbers. The difference between medical needs and operational readiness prevents ECMO technology from spreading to additional hospitals and new markets which maintains its current geographic distribution and restricts market expansion and competitive competition.
Supply Chain Landscape
1
ECMO Components Production
Medtronic plcTerumo CorporationFresenius Medical Care
2
ECMO Machine Assembly
Getinge ABLivaNova PLCMedtronic plc
3
Distribution & Service
Getinge ABTerumo CorporationFresenius Medical Care
4
Clinical Critical Care
tertiary care hospitalscardiac surgery centersrespiratory intensive care units
1
ECMO Components Production
Medtronic plcTerumo CorporationFresenius Medical Care
2
ECMO Machine Assembly
Getinge ABLivaNova PLCMedtronic plc
3
Distribution & Service
Getinge ABTerumo CorporationFresenius Medical Care
4
Clinical Critical Care
tertiary care hospitalscardiac surgery centersrespiratory intensive care units
Use Cases of ECMO Machine in Respiratory Support & Cardiac Support
Respiratory Support : The ECMO Machine operates in venovenous mode to deliver extracorporeal membrane oxygenation for patients with severe acute respiratory distress syndrome and refractory hypoxemia in intensive care units when conventional ventilation fails to maintain proper oxygenation support. The VV ECMO system performs blood oxygenation and decarboxylation outside the body to decrease the requirement for elevated ventilator pressures which protects lungs from injury while providing continuous heart and lung support in critical care environments. The respiratory applications segment achieved USD 302.63 million in revenue during 2024 and experts predict this market will expand at 4.1% annually until 2030 to become the dominant application for ECMO Machine and their components. The market leaders Getinge AB and Medtronic plc maintain their dominance through their complete VV ECMO systems and sophisticated oxygenation technology while Terumo Corporation and Fresenius Medical Care use their blood pump and circuit and monitoring system expertise to create more dependable and secure and user friendly systems for extended respiratory support needs. The market demand for components exceeds standalone ECMO Machine by 67.4% to 32.60% because components make up 67.4% of total demand in 2024.
Cardiac Support : The main applications of cardiac support systems use venoarterial configurations because these setups enable ECMO Machine to perform both extracorporeal membrane oxygenation and hemodynamic assistance for patients with cardiogenic shock and post cardiotomy failure and high risk cardiac surgery patients. The VA ECMO system delivers strong cardiopulmonary assistance through heart and lung bypass to maintain blood circulation and enable myocardial healing or permanent mechanical support or heart transplant procedures in specialized cardiac centers. The cardiac applications segment generated $172.09 million in revenue during 2024 and experts predict this market will expand at 7.2% annually until 2030 because more hospitals are adopting ECMO Machine for their tertiary cardiac surgery units and hybrid operating rooms. The cardiac support market leadership of LivaNova PLC and Terumo Corporation stems from their cardiovascular surgery and perfusion system expertise while Medtronic plc and Getinge AB maintain their market position through their diverse VA ECMO consoles and cannulation solutions and complete cardiac care system integration.
Emergency ECPR : The emergency use of VA ECMO Machine in extracorporeal cardiopulmonary resuscitation enables healthcare providers to restore blood circulation through patients who experience cardiac arrest that does not only respond to standard emergency resuscitation techniques. The mobile ECMO Machine systems focus on quick setup and easy movement between locations while providing complete integration with defibrillation equipment and imaging systems and hemodynamic monitoring tools to support specialized teams performing emergency life support in hospital departments and catheterization labs and transfer situations. The ECPR market segment achieved USD 58.08 million in 2024 revenue and shows the highest growth rate at 8.07% CAGR until 2030 because of increasing ECPR programs and standardized treatment protocols and better survival outcomes for specific cardiac arrest cases. The emergency ECMO market depends on Getinge AB and Terumo Corporation for its rugged transportable ECMO Machine and easy to use circuit designs. The emergency ECMO market depends on Fresenius Medical Care and Medtronic plc for their expertise in critical care technologies and extracross the board blood management solutions which enable them to deliver dependable high flow systems for urgent cardiopulmonary support in emergency medical situations.
Impact of Industry Transitions on the ECMO Machine Market
As a core segment of the Medical Device industry,
the ECMO Machine market develops in line with broader industry shifts.
Over recent years, transitions such as AI Enabled ECMO Workflows and Expansion into Decentralized Care have redefined priorities
across the Medical Device sector,
influencing how the ECMO Machine market evolves in terms of demand, applications and competitive dynamics.
These transitions highlight the structural changes shaping long-term growth opportunities.
01
AI Enabled ECMO Workflows
The ECMO Machine is evolving into a pivotal smart node within intensive care units, driven by the digitization of critical care operations. Enhanced with predictive analytics, automated alarm management, and seamless electronic health record interoperability, these machines not only optimize real time extracorporeal membrane oxygenation settings but also facilitate a cohesive data ecosystem among adjacent critical care devices. This transformation is strategically positioned to significantly influence the U.S. and China markets, with AI enabled ECMO workflows projected to contribute an additional $20 million in revenue by 2030. By streamlining clinical decision making and reducing staff workload, this transition underscores the ECMO Machines critical role in advancing patient care and operational efficiency in acute care environments. This industry transition is expected to add $19 million in the industry revenue between 2024 and 2030.
02
Expansion into Decentralized Care
The ECMO Machine undergoes a major transformation to operate outside traditional tertiary hospitals through mobile ECMO retrieval teams and regional heart and lung centers. The development of ECMO Machine focuses on creating compact designs with user friendly interfaces and disposable modules which enable fast deployment and transportation. The development of emergency medical services and prehospital care continues through the integration of extracorporeal membrane oxygenation capabilities by ambulance services and aeromedical providers which requires new training approaches and payment systems and collaborative relationships between cardiology and thoracic surgery and critical care networks.